The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.
Sources:
https://patents.google.com/patent/US10130701B2,
https://patents.justia.com/patent/10130701,
Local copy.
Patent.
https://www.pirbright.ac.uk/.
Foundation.
https://AFinalWarning.com/531723.html.
Blog.
https://patriots4truth.org/2020/01/28/corona-virus-is-a-globalist-bioweapon/.
Blog.
https://americans4innovation.blogspot.com/2020/01/coronavirus-traced-to-british-crown.html.
Blog.
https://americans4innovation.blogspot.com/2020/02/coronavirus-uncovers-rothschild-lord.html.
Blog.
Related:
https://www.ajmc.com/view/nih-bill-and-melinda-gates-foundation-collaborate-to-develop-genebased-hiv-treatment.
Research Journal.